|
Name |
Hexylitaconic Acid
|
Molecular Formula | C11H18O4 | |
IUPAC Name* |
2-hexyl-3-methylidenebutanedioic acid
|
|
SMILES |
CCCCCCC(C(=C)C(=O)O)C(=O)O
|
|
InChI |
InChI=1S/C11H18O4/c1-3-4-5-6-7-9(11(14)15)8(2)10(12)13/h9H,2-7H2,1H3,(H,12,13)(H,14,15)
|
|
InChIKey |
HKMDCNSGDQBQLI-UHFFFAOYSA-N
|
|
Synonyms |
Hexylitaconic Acid; (-)-Hexylitaconic acid; 2-hexyl-3-methylidenebutanedioic acid; (?)-Hexylitaconic acid; MLS000876945; CHEMBL199341; MEGxm0_000045; SCHEMBL9231241; ACon0_000685; ACon1_001940; 2-Hexyl-3-methylenesuccinic acid; CHEBI:188754; HMS2268D03; BDBM50475573; 2-methylene-3-hexyl-butanedioic acid; BS-1561; NCGC00179983-01; 94513-51-6; SMR000440626; BRD-A85835458-001-01-9; 723302-30-5
|
|
CAS | NA | |
PubChem CID | 11447214 | |
ChEMBL ID | CHEMBL199341 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 214.26 | ALogp: | 2.9 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 74.6 | Aromatic Rings: | 0 |
Heavy Atoms: | 15 | QED Weighted: | 0.481 |
Caco-2 Permeability: | -5.634 | MDCK Permeability: | 0.00307406 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.031 | 20% Bioavailability (F20%): | 0.001 |
30% Bioavailability (F30%): | 0.012 |
Blood-Brain-Barrier Penetration (BBB): | 0.649 | Plasma Protein Binding (PPB): | 88.07% |
Volume Distribution (VD): | 0.295 | Fu: | 8.16% |
CYP1A2-inhibitor: | 0.012 | CYP1A2-substrate: | 0.094 |
CYP2C19-inhibitor: | 0.024 | CYP2C19-substrate: | 0.058 |
CYP2C9-inhibitor: | 0.003 | CYP2C9-substrate: | 0.906 |
CYP2D6-inhibitor: | 0.013 | CYP2D6-substrate: | 0.093 |
CYP3A4-inhibitor: | 0.009 | CYP3A4-substrate: | 0.006 |
Clearance (CL): | 3.364 | Half-life (T1/2): | 0.858 |
hERG Blockers: | 0.003 | Human Hepatotoxicity (H-HT): | 0.156 |
Drug-inuced Liver Injury (DILI): | 0.063 | AMES Toxicity: | 0.001 |
Rat Oral Acute Toxicity: | 0.266 | Maximum Recommended Daily Dose: | 0.004 |
Skin Sensitization: | 0.334 | Carcinogencity: | 0.02 |
Eye Corrosion: | 0.98 | Eye Irritation: | 0.989 |
Respiratory Toxicity: | 0.107 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002268 | 0.867 | D0E4WR | 0.345 | ||||
ENC002389 | 0.679 | D0AY9Q | 0.328 | ||||
ENC001885 | 0.472 | D00ENY | 0.306 | ||||
ENC004866 | 0.472 | D0Y3KG | 0.300 | ||||
ENC005324 | 0.472 | D0D9NY | 0.291 | ||||
ENC000030 | 0.404 | D0Z0MG | 0.286 | ||||
ENC003844 | 0.393 | D0I4DQ | 0.286 | ||||
ENC004060 | 0.393 | D0FD0H | 0.286 | ||||
ENC002444 | 0.392 | D02GIU | 0.275 | ||||
ENC001612 | 0.383 | D06FEA | 0.271 |